AD
ADMA Biologics
ADMA · NASDAQ
$9.62 +2.01% (+$0.19)
1M -1.33%
Market Cap $2.23B
P/E Ratio 13.20x
Div. Yield -
ROE 39.59%
Bulios Fair Price
$6.29
34.6% downside
Trenutna cena
$9.62
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ADMA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
70 /100
Cheap P/E 13.20x
EV/EBITDA 9.78x
P/S 4.35x
Growth
100 /100
Growing Rev. growth 49.05%
Book val. growth 46.45%
EPS growth N/A
Profitability
100 /100
Strong Gross margin 64.71%
Net margin 32.98%
Op. margin 42.26%
Quality
94 /100
Excellent ROIC 27.55%
ROE 39.59%
ROA 24.69%
Debt
95 /100
Low Debt/Equity 0.50x
Current ratio 6.97x
Int. coverage 25.53x
Stability
42 /100
Moderate Beta 0.77x
Rev. volatility 27.01%
EPS volatility 407.63%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ADMA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Adam S. Grossman
Employees
644
Headquarters
Ramsey
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report